Literature DB >> 15276425

Arsenic and atherosclerosis.

Petia P Simeonova1, Michael I Luster.   

Abstract

Epidemiological studies have demonstrated a correlation between environmental or occupational arsenic exposure and a risk of vascular diseases related to atherosclerosis. Studies summarized in this review suggest that arsenic induces endothelial dysfunction, including inflammatory and coagulating activity as well as impairs nitric oxide (NO) balance. This may provide the pathophysiological basis for atherogenic potential of arsenic. Consistent with these data, arsenic accelerates atherosclerosis in apolipoprotein E (ApoE) deficient mice, a model of human atherosclerosis.

Entities:  

Mesh：

Year:  2004        PMID： 15276425     DOI： 10.1016/j.taap.2003.10.018

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


  39 in total

1.  Work, obesity, and occupational safety and health.

Authors:  Paul A Schulte; Gregory R Wagner; Aleck Ostry; Laura A Blanciforti; Robert G Cutlip; Kristine M Krajnak; Michael Luster; Albert E Munson; James P O'Callaghan; Christine G Parks; Petia P Simeonova; Diane B Miller
Journal:  Am J Public Health       Date:  2007-01-31       Impact factor: 9.308

2.  Association between arsenic exposure from drinking water and plasma levels of cardiovascular markers.

Authors:  Fen Wu; Farzana Jasmine; Muhammad G Kibriya; Mengling Liu; Oktawia Wójcik; Faruque Parvez; Ronald Rahaman; Shantanu Roy; Rachelle Paul-Brutus; Stephanie Segers; Vesna Slavkovich; Tariqul Islam; Diane Levy; Jacob L Mey; Alexander van Geen; Joseph H Graziano; Habibul Ahsan; Yu Chen
Journal:  Am J Epidemiol       Date:  2012-04-24       Impact factor: 4.897

3.  Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation.

Authors:  Koren K Mann; Alessandra M S Padovani; Qi Guo; April L Colosimo; Ho-Young Lee; Jonathan M Kurie; Wilson H Miller
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

4.  Trace Elements and Paraoxonase-1 Activity in Lower Extremity Artery Disease.

Authors:  Joaquim Rovira; Anna Hernández-Aguilera; Fedra Luciano-Mateo; Noemí Cabré; Gerard Baiges-Gaya; Martí Nadal; Vicente Martín-Paredero; Jordi Camps; Jorge Joven; José L Domingo
Journal:  Biol Trace Elem Res       Date:  2018-03-10       Impact factor: 3.738

5.  Aortic smooth muscle cell alterations in mice systemically exposed to arsenic.

Authors:  Shih-Chieh Chen; Shin-Yin Huang; Wen-Ting Lin; Rei-Cheng Yang; Hsin-Su Yu
Journal:  Heart Vessels       Date:  2015-07-02       Impact factor: 2.037

6.  Dual actions involved in arsenite-induced oxidative DNA damage.

Authors:  Xu-Jun Qin; Laurie G Hudson; Wenlan Liu; Wei Ding; Karen L Cooper; Ke Jian Liu
Journal:  Chem Res Toxicol       Date:  2008-08-16       Impact factor: 3.739

7.  Gene-arsenic interaction in longitudinal changes of blood pressure: Findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh.

Authors:  Shohreh F Farzan; Margaret R Karagas; Jieying Jiang; Fen Wu; Mengling Liu; Jonathan D Newman; Farzana Jasmine; Muhammad G Kibriya; Rachelle Paul-Brutus; Faruque Parvez; Maria Argos; Molly Scannell Bryan; Mahbub Eunus; Alauddin Ahmed; Tariqul Islam; Muhammad Rakibuz-Zaman; Rabiul Hasan; Golam Sarwar; Vesna Slavkovich; Joseph Graziano; Habibul Ahsan; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2015-07-26       Impact factor: 4.219

8.  Induction of heme oxygenase 1 by arsenite inhibits cytokine-induced monocyte adhesion to human endothelial cells.

Authors:  Xi Sun; Jingbo Pi; Wenlan Liu; Laurie G Hudson; Ke Jian Liu; Changjian Feng
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-06       Impact factor: 4.219

9.  Arsenic alters vascular smooth muscle cell focal adhesion complexes leading to activation of FAK-src mediated pathways.

Authors:  Michele D Pysher; Qin M Chen; Richard R Vaillancourt
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-11       Impact factor: 4.219

10.  Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06.

Authors:  David Melzer; Neil E Rice; Ceri Lewis; William E Henley; Tamara S Galloway
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.